Many proinflammatory cytokines, including IFN-gamma [24,25] and Eotaxin2/CCL24 [26] which are elevated in our study’s group with sputum production (Table 3), have been shown to be correlated with worse clinical outcomes associated with COVID-19. This evidence concerns the gene IFNG and COVID-19.